{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:15:48Z","timestamp":1743394548808,"version":"3.40.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873641","No. 82070817"],"award-info":[{"award-number":["No. 81873641","No. 82070817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2017-I2M-1-001"],"award-info":[{"award-number":["2017-I2M-1-001"]}]},{"name":"The Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2023-PT320-10"],"award-info":[{"award-number":["2023-PT320-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02504-1","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:45:59Z","timestamp":1732175159000},"page":"967-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["48-Year clinical experience and genetic analysis of pediatric primary hyperparathyroidism from a single center in China"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-1464","authenticated-orcid":false,"given":"Yingyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunwu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-8789","authenticated-orcid":false,"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-5177","authenticated-orcid":false,"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"2504_CR1","doi-asserted-by":"publisher","unstructured":"Fraser WD, Hyperparathyroidism (2009) Lancet. Jul 11;374(9684):145\u2013\u200958. https:\/\/doi.org\/10.1016\/s0140-6736(09)60507-9","DOI":"10.1016\/s0140-6736(09)60507-9"},{"key":"2504_CR2","doi-asserted-by":"publisher","unstructured":"Lawson ML, Miller SF, Ellis G, Filler RM, Kooh SW (1996) Primary hyperparathyroidism in a paediatric hospital. QJM. \/12\/\/ 1996;89(12):921\u2013932. https:\/\/doi.org\/10.1093\/qjmed\/89.12.921","DOI":"10.1093\/qjmed\/89.12.921"},{"key":"2504_CR3","doi-asserted-by":"publisher","unstructured":"Kollars J, Zarroug AE, van Heerden J et al (2005) Primary hyperparathyroidism in pediatric patients. Pediatrics. \/04\/\/ 2005;115(4):974\u2013980. https:\/\/doi.org\/10.1542\/peds.2004-0804","DOI":"10.1542\/peds.2004-0804"},{"key":"2504_CR4","doi-asserted-by":"publisher","unstructured":"El Allali Y, Hermetet C, Bacchetta J, et al. Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population. Eur J Endocrinol. 2021\/02\/\/ 2021;184(2):347\u2013355. https:\/\/doi.org\/10.1530\/EJE-20-1119","DOI":"10.1530\/EJE-20-1119"},{"issue":"6","key":"2504_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/cen.13453","volume":"2017","author":"W Wang","year":"2017","unstructured":"Wang W, Kong J, Nie M et al (2017) Primary hyperparathyroidism in Chinese children and adolescents: a single-centre experience at Peking Union Medical College Hospital. Clin Endocrinol 2017(6):865\u2013873. https:\/\/doi.org\/10.1111\/cen.13453","journal-title":"Clin Endocrinol"},{"key":"2504_CR6","doi-asserted-by":"publisher","unstructured":"George J, Acharya SV, Bandgar TR, Menon PS, Shah NS (2010) Primary hyperparathyroidism in children and adolescents. Indian J Pediatr. \/02\/\/ 2010;77(2):175\u2013178. https:\/\/doi.org\/10.1007\/s12098-009-0289-5","DOI":"10.1007\/s12098-009-0289-5"},{"issue":"Suppl 2","key":"2504_CR7","first-page":"N44","volume":"2002\/11\/","author":"SC Hsu","year":"2002","unstructured":"Hsu SC, Levine MA (2002) Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children\u2019s Center experience 1984\u20132001. J Bone Min Res 2002\/11\/(Suppl 2):N44\u201350","journal-title":"J Bone Min Res"},{"key":"2504_CR8","doi-asserted-by":"publisher","unstructured":"Pashtan I, Grogan RH, Kaplan SP et al (2013) Primary hyperparathyroidism in adolescents: the same but different. Pediatr Surg Int. \/03\/\/ 2013;29(3):275\u2013279. https:\/\/doi.org\/10.1007\/s00383-012-3222-3","DOI":"10.1007\/s00383-012-3222-3"},{"key":"2504_CR9","doi-asserted-by":"publisher","unstructured":"Roizen J, Levine MA (2014) A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab. 99(12):4555\u20134564. https:\/\/doi.org\/10.1210\/jc.2014-2268","DOI":"10.1210\/jc.2014-2268"},{"key":"2504_CR10","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE, Hyperparathyroidism (2018) Lancet. Jan 13;391(10116):168\u2013178. https:\/\/doi.org\/10.1016\/s0140-6736(17)31430-7","DOI":"10.1016\/s0140-6736(17)31430-7"},{"issue":"9","key":"2504_CR11","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab Sep 97(9):2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab Sep"},{"key":"2504_CR12","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ et al (2022) Nov. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res.;37(11):2293\u20132314. https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"2504_CR13","doi-asserted-by":"publisher","unstructured":"Ahmad S, Kuraganti G, Steenkamp D (Mar 2015) Hypercalcemic crisis: a clinical review. Am J Med 128(3):239\u2013245. https:\/\/doi.org\/10.1016\/j.amjmed.2014.09.030","DOI":"10.1016\/j.amjmed.2014.09.030"},{"key":"2504_CR14","unstructured":"DeLellis RLC, Arnold A, Lloy R, Bilezikian J, Mete O, Eng C (2017) Tumors of the parathyroid glands. In: Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, edsWHO Classification of Tumours of Endocrine Organs. 4th ed. IARC.;2017:145\u2013159"},{"issue":"7","key":"2504_CR15","doi-asserted-by":"publisher","first-page":"R441","DOI":"10.1530\/erc-19-0135","volume":"26","author":"F Cetani","year":"2019","unstructured":"Cetani F, Marcocci C, Torregrossa L, Pardi E (2019) Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer Jul 26(7):R441\u2013r464. https:\/\/doi.org\/10.1530\/erc-19-0135","journal-title":"Endocr Relat Cancer Jul"},{"issue":"1","key":"2504_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjsurg.2016.03.019","volume":"213","author":"I Lou","year":"2017","unstructured":"Lou I, Schneider DF, Sippel RS, Chen H, Elfenbein DM (2017) The changing pattern of diagnosing primary hyperparathyroidism in young patients. Am J Surg Jan 213(1):146\u2013150. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.03.019","journal-title":"Am J Surg Jan"},{"issue":"11","key":"2504_CR17","doi-asserted-by":"publisher","first-page":"e0166634","DOI":"10.1371\/journal.pone.0166634","volume":"11","author":"J Kong","year":"2016","unstructured":"Kong J, Wang O, Nie M et al (2016) Clinical and genetic analysis of multiple endocrine neoplasia type 1-Related primary hyperparathyroidism in Chinese. PLoS ONE 11(11):e0166634. https:\/\/doi.org\/10.1371\/journal.pone.0166634","journal-title":"PLoS ONE"},{"issue":"2","key":"2504_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cen.12461","volume":"81","author":"J Kong","year":"2014","unstructured":"Kong J, Wang O, Nie M et al (2014) Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese. Clin Endocrinol (Oxf) Aug 81(2):222\u2013230. https:\/\/doi.org\/10.1111\/cen.12461","journal-title":"Clin Endocrinol (Oxf) Aug"},{"issue":"11","key":"2504_CR19","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1210\/jc.2003-030997","volume":"88","author":"AM Da Silva","year":"2003","unstructured":"Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM (2003) A novel germ-line point mutation in RET exon 8 (gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab Nov 88(11):5438\u20135443. https:\/\/doi.org\/10.1210\/jc.2003-030997","journal-title":"J Clin Endocrinol Metab Nov"},{"issue":"12","key":"2504_CR20","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/jbmr.3854","volume":"34","author":"Y Wang","year":"2019","unstructured":"Wang Y, Nie M, Wang O et al (2019) Genetic screening in a large Chinese cohort of Childhood Onset Hypoparathyroidism by Next-Generation sequencing combined with TBX1-MLPA. J Bone Min Res Dec 34(12):2254\u20132263. https:\/\/doi.org\/10.1002\/jbmr.3854","journal-title":"J Bone Min Res Dec"},{"key":"2504_CR21","doi-asserted-by":"publisher","unstructured":"Richards S, Aziz N, Bale S et al (May 2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","DOI":"10.1038\/gim.2015.30"},{"issue":"9","key":"2504_CR22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jbmr.4883","volume":"38","author":"A Song","year":"2023","unstructured":"Song A, Yang Y, Jiang Y et al (2023) Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study. J Bone Min Res Sep 38(9):1322\u20131333. https:\/\/doi.org\/10.1002\/jbmr.4883","journal-title":"J Bone Min Res Sep"},{"issue":"3","key":"2504_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab Mar 98(3):1122\u20131129. https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab Mar"},{"key":"2504_CR24","doi-asserted-by":"publisher","first-page":"602221","DOI":"10.3389\/fendo.2021.602221","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Fan Y, Zhang Z, Yue H (2021) Clinical characteristics of primary hyperparathyroidism: 15-Year experience of 457 patients in a single Center in China. Front Endocrinol (Lausanne) 12:602221. https:\/\/doi.org\/10.3389\/fendo.2021.602221","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2504_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"Zhao L, Liu JM, He XY et al (2013) The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab Feb 98(2):721\u2013728. https:\/\/doi.org\/10.1210\/jc.2012-2914","journal-title":"J Clin Endocrinol Metab Feb"},{"issue":"6","key":"2504_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archsurg.134.6.651","volume":"134","author":"CR Harman","year":"1999","unstructured":"Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K (1999) Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg Jun 134(6):651\u2013655 discussion 655-6. https:\/\/doi.org\/10.1001\/archsurg.134.6.651","journal-title":"Arch Surg Jun"},{"issue":"3","key":"2504_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000112592","volume":"69","author":"E Mallet","year":"2008","unstructured":"Mallet E, Working Group on Calcium M (2008) Primary hyperparathyroidism in neonates and childhood. The French experience (1984\u20132004). Horm Res 2008 69(3):180\u2013188. https:\/\/doi.org\/10.1159\/000112592","journal-title":"Horm Res 2008"},{"key":"2504_CR28","doi-asserted-by":"publisher","unstructured":"Li CC, Yang C, Wang S, Zhang J, Kong XR, Ouyang J. A 10-year retrospective study of primary hyperparathyroidism in children. Exp Clin Endocrinol Diabetes. 2012\/04\/\/ 2012;120(4):229\u2013233. https:\/\/doi.org\/10.1055\/s-0032-1301895","DOI":"10.1055\/s-0032-1301895"},{"key":"2504_CR29","doi-asserted-by":"publisher","unstructured":"Sharanappa V, Mishra A, Bhatia V et al (2021) Pediatric Primary Hyperparathyroidism: Experience in a Tertiary Care Referral Center in a Developing Country Over Three Decades. World J Surg. \/02\/\/ 2021;45(2):488\u2013495. https:\/\/doi.org\/10.1007\/s00268-020-05816-4","DOI":"10.1007\/s00268-020-05816-4"},{"key":"2504_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110482","author":"K McKenna","year":"2021","unstructured":"McKenna K, Dunbar NS, Parham K (2021) Why is primary hyperparathyroidism more severe in children? Med Hypotheses. https:\/\/doi.org\/10.1016\/j.mehy.2020.110482. \/02\/\/ 2021;147:110482","journal-title":"Med Hypotheses"},{"issue":"9","key":"2504_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcma.2012.06.012","volume":"75","author":"J Roizen","year":"2012","unstructured":"Roizen J, Levine MA (2012) Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc Sep 75(9):425\u2013434. https:\/\/doi.org\/10.1016\/j.jcma.2012.06.012","journal-title":"J Chin Med Assoc Sep"},{"issue":"4","key":"2504_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4274\/Jcrpe.1060","volume":"5","author":"D Dutta","year":"2013","unstructured":"Dutta D, Kumar M, Das RN et al (2013) Primary hyperparathyroidism masquerading as rickets: diagnostic challenge and treatment outcomes. J Clin Res Pediatr Endocrinol 5(4):266\u2013269. https:\/\/doi.org\/10.4274\/Jcrpe.1060","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"2504_CR33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.bone.2007.10.006","volume":"42","author":"P Pitukcheewanont","year":"2008","unstructured":"Pitukcheewanont P, Numbenjapon N, Costin G (2008) Ectopic thymic parathyroid adenoma and vitamin D deficiency rickets: a 5-year-follow-up case report and review of literature. Bone Apr 42(4):819\u2013824. https:\/\/doi.org\/10.1016\/j.bone.2007.10.006","journal-title":"Bone Apr"},{"issue":"4","key":"2504_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.clnu.2015.05.019","volume":"35","author":"Z Ning","year":"2016","unstructured":"Ning Z, Song S, Miao L et al (2016) High prevalence of vitamin D deficiency in urban health checkup population. Clin Nutr Aug 35(4):859\u2013863. https:\/\/doi.org\/10.1016\/j.clnu.2015.05.019","journal-title":"Clin Nutr Aug"},{"issue":"2","key":"2504_CR35","first-page":"158","volume":"45","author":"JP Bilezikian","year":"2000","unstructured":"Bilezikian JP, Meng X, Shi Y, Silverberg SJ (2000) Primary hyperparathyroidism in women: a tale of two cities\u2013New York and Beijing. Int J Fertil Womens Med Mar-Apr 45(2):158\u2013165","journal-title":"Int J Fertil Womens Med Mar-Apr"},{"issue":"9","key":"2504_CR36","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker MD, Cong E, Lee JA et al (2015) Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metab Sep 100(9):3443\u20133451. https:\/\/doi.org\/10.1210\/jc.2015-2022","journal-title":"J Clin Endocrinol Metab Sep"},{"issue":"1","key":"2504_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euf.2017.04.001","volume":"3","author":"OA Raheem","year":"2017","unstructured":"Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD (2017) Burden of Urolithiasis: Trends in Prevalence, treatments, and costs. Eur Urol Focus Feb 3(1):18\u201326. https:\/\/doi.org\/10.1016\/j.euf.2017.04.001","journal-title":"Eur Urol Focus Feb"},{"key":"2504_CR38","doi-asserted-by":"publisher","unstructured":"Wang P, Zhang H, Zhou J et al (2021) Study of risk factor of urinary calculi according to the association between stone composition with urine component. Sci Rep. Apr 22.;11(1):8723. https:\/\/doi.org\/10.1038\/s41598-021-87733-7","DOI":"10.1038\/s41598-021-87733-7"},{"issue":"5","key":"2504_CR39","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/MLG.0b013e3180337d95","volume":"117","author":"F Venail","year":"2007","unstructured":"Venail F, Nicollas R, Morin D et al (2007) Solitary parathyroid adenoma: a rare cause of primary hyperparathyroidism in children. Laryngoscope May 117(5):946\u2013949. https:\/\/doi.org\/10.1097\/MLG.0b013e3180337d95","journal-title":"Laryngoscope May"},{"key":"2504_CR40","doi-asserted-by":"publisher","unstructured":"Lib\u00e1nsk\u00fd P, Astl J, Ad\u00e1mek S, et al. Surgical treatment of primary hyperparathyroidism in children: report of 10 cases. Int J Pediatr Otorhinolaryngol. 2008\/08\/\/ 2008;72(8):1177\u20131182. https:\/\/doi.org\/10.1016\/j.ijporl.2008.04.005","DOI":"10.1016\/j.ijporl.2008.04.005"},{"issue":"7","key":"2504_CR41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","volume":"6","author":"I Lemmens","year":"1997","unstructured":"Lemmens I, Van de Ven WJ, Kas K et al (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet Jul 6(7):1177\u20131183. https:\/\/doi.org\/10.1093\/hmg\/6.7.1177","journal-title":"Hum Mol Genet Jul"},{"issue":"1\u20132","key":"2504_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/elps.200390023","volume":"24","author":"M Cr\u00e9pin","year":"2003","unstructured":"Cr\u00e9pin M, Escande F, Pigny P et al (2003) Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis. Electrophoresis Jan 24(1\u20132):26\u201333. https:\/\/doi.org\/10.1002\/elps.200390023","journal-title":"Electrophoresis Jan"},{"issue":"7","key":"2504_CR43","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/hmg\/6.7.1169","volume":"6","author":"SK Agarwal","year":"1997","unstructured":"Agarwal SK, Kester MB, Debelenko LV et al (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet Jul 6(7):1169\u20131175. https:\/\/doi.org\/10.1093\/hmg\/6.7.1169","journal-title":"Hum Mol Genet Jul"},{"issue":"2","key":"2504_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1086\/301729","volume":"62","author":"JH Bassett","year":"1998","unstructured":"Bassett JH, Forbes SA, Pannett AA et al (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet Feb 62(2):232\u2013244. https:\/\/doi.org\/10.1086\/301729","journal-title":"Am J Hum Genet Feb"},{"issue":"11","key":"2504_CR45","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S et al (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab Nov 89(11):5583\u20135591. https:\/\/doi.org\/10.1210\/jc.2004-0294","journal-title":"J Clin Endocrinol Metab Nov"},{"issue":"2","key":"2504_CR46","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C et al (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab Feb 98(2):E403\u2013E408. https:\/\/doi.org\/10.1210\/jc.2012-2789","journal-title":"J Clin Endocrinol Metab Feb"},{"key":"2504_CR47","doi-asserted-by":"publisher","unstructured":"Song A, Yang Y, Wang Y et al (2020) Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients. Endocrine Practice. 10\/01\/2020;26(10):1093\u20131104. https:\/\/doi.org\/10.4158\/EP-2020-0132","DOI":"10.4158\/EP-2020-0132"},{"issue":"5","key":"2504_CR48","first-page":"1075","volume":"56","author":"YH Chou","year":"1995","unstructured":"Chou YH, Pollak MR, Brandi ML et al (1995) Mutations in the human ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet May 56(5):1075\u20131079","journal-title":"Am J Hum Genet May"},{"issue":"1\u20132","key":"2504_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cccn.2005.04.026","volume":"360","author":"CW Lam","year":"2005","unstructured":"Lam CW, Lee KF, Chan AO, Poon PM, Law TY, Tong SF (2005) Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia. Clin Chim Acta Oct 360(1\u20132):167\u2013172. https:\/\/doi.org\/10.1016\/j.cccn.2005.04.026","journal-title":"Clin Chim Acta Oct"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02504-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02504-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02504-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T08:50:38Z","timestamp":1743324638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02504-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02504-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}